Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | PGD | P52209 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670184 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5791149 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5790915 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5788771 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5792045 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL671072 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5792603 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5042 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL669339 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL159295 | 1.00 | PDE4A (0.50) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2447 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12553073-B2 | Galactose to tagatose isomerization at moderate temperatures with high conversion and productivity | TRUSTEES OF TUFTS COLLEGE (US) | 2026-02-17 | — | — | US | claimed |
| US-20250277195-A1 | MATURE POLYPEPTIDE SEQUENCE FOR SYNTHESIZING OLIGOSACCHARIDE AND USE | Shandong Henglu Biotech. Co., Ltd. (CN) | 2025-09-04 | — | — | US | claimed |
| CN-119639887-B | Primer and probe combination and kit for detecting galactose-1-phosphate uridine transferase gene polymorphism | 深圳会众生物技术有限公司 | 2025-06-24 | — | — | CN | claimed |
| WO-2025079998-A1 | CORYNEBACTERIUM SP. STRAIN WITH CARRAGEENAN DEGRADATION AND GALACTOSE UTILIZATION ABILITIES INTRODUCED THEREINTO AND METHOD FOR PRODUCING HISTIDINE FROM SEAWEED USING SAME | 고려대학교 산학협력단 | 2025-04-17 | — | — | WO | claimed |
| CN-119639887-A | Primer and probe combination and kit for detecting galactose-1-phosphate uridine transferase gene polymorphism | 深圳会众生物技术有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119432793-A | Mature polypeptide sequence for synthesizing HMOs and application thereof | 山东恒鲁生物科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118056902-B | Mature polypeptide sequence for synthesizing HMOs and application thereof | 山东恒鲁生物科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| EP-4500182-A1 | PROGNOSTIC BIOMARKERS | The University of Liverpool (GB) | 2025-02-05 | — | — | EP | claimed |
| EP-4495231-A1 | MATURE POLYPEPTIDE SEQUENCE FOR SYNTHESIZING OLIGOSACCHARIDE AND USE | Shandong Henglu Biotech. Co., Ltd. (CN) | 2025-01-22 | — | — | EP | claimed |
| US-20250001008-A1 | GENE THERAPY FOR GALACTOSEMIA | BRIDGEBIO SERVICES INC. | 2025-01-02 | — | — | US | claimed |
| WO-1998025940-A1 | INHIBITORS OF GLYCOSYLTRANSFERASES | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-06-18 | — | — | WO | claimed |
| EP-0763132-A4 | ASSAY FOR ENZYME ACTIVITY USING A MICROFLUOROMETRIC ASSAY | ISOLAB INC (US) | 1997-06-18 | — | — | EP | claimed |
| EP-0763132-A1 | ASSAY FOR ENZYME ACTIVITY USING A MICROFLUOROMETRIC ASSAY | ISOLAB, INC. (US) | 1997-03-19 | — | — | EP | claimed |
| US-5538857-A | FLUORESCENCE | ISOLAB, INC. (US) | 1996-07-23 | — | — | US | claimed |
| WO-1996010400-A1 | GENE THERAPY VECTORS AND VACCINES BASED ON NON-SEGMENTED NEGATIVES STRANDED RNA VIRUSES | THE UAB RESEARCH FOUNDATION (US) | 1996-04-11 | — | — | WO | claimed |
| WO-1995033072-A1 | ASSAY FOR ENZYME ACTIVITY USING A MICROFLUOROMETRIC ASSAY | ISOLAB, INC. (US) | 1995-12-07 | — | — | WO | claimed |
| WO-1994001448-A1 | OLIGONUCLEOTIDES MODIFIED WITH CONJUGATE GROUPS | PHARMAGENICS, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| US-4923796-A | ADENOSINE DIPHOSPHATE, KINASE, PHOSPHORYLATED SUBSTRATE, NICOTINAMIDE-ADENINE DINUCLEOTIDE (PHOSPHATE), OXIDOREDUCTASE | BOEHRINGER MANNHEIM GMBH (DE) | 1990-05-08 | — | — | US | claimed |
| EP-0009076-B1 | METHOD FOR THE QUANTITATIVE ENZYMATIC DETERMINATION OF ADP AND REAGENT FOR THIS METHOD | Roche Diagnostics GmbH (DE) | 1981-07-29 | — | — | EP | claimed |
| EP-0009076-A1 | Method for the quantitative enzymatic determination of ADP and reagent for this method | Roche Diagnostics GmbH (DE) | 1980-04-02 | — | — | EP | claimed |